TGFB1 and pancreatic neoplasm: Despite the fact that inactivating mutations in the canonical TGFβ pathways in colorectal and pancreatic tumors are wide spread, cells isolated from other tumor types preserve the functionality of the canonical TGFβ signaling components and achieve TGFβ growth resistance by altering other aspects of the pathways [5].